–News Direct–
By Meg Flippin, Benzinga
![Click here to learn more about Rexis Biotechs crowdfunding raise, and how to invest](https://www.cloudprwire.us/wp-content/uploads/2024/03/uHjAdJjK.png)
Its no secret that many people turn to chugging caffeine-induced drinks to get them through the day. But what they may not realize is too much caffeine can be a bad thing. Jitters, elevated heart rates and anxiety are just some of the side effects many consumers just learn to accept.
But caffeine overload doesnt have to be the foregone conclusion just to get your caffeine fix. Products like Rexis Biotech Inc.s Hydro-CaffeineTM are revolutionizing the energy drink market. Thanks to its nanotechnology, the Delaware biotech firm says it has created a better caffeine that gives you energy without all the bad side effects.
Quadruple The Effects For Less
Hydro-Caffeine can be found in Rexiss new groundbreaking energy drink Squared Energy, a product line extension to their already successful Squared brand which is available in over 2,000+ retailers in 10 states across the country. It is created using the companys proprietary co-crystal that amplifies the effects by increasing the bioavailability of its caffeine co-crystal by four to five times. Rexis is taking it up a level with this drink by fusing Hydro-Caffeine with naturally occurring Hemp Delta-9 THC + broad-spectrum CBD to create a singular polymorph molecule in which all three work together for the ultimate entourage effect. That creates a unique experience for consumers highlighted by clear-headed, focused energy without any jitters or anxiety, according to Rexis. The first two flavors theyll be bringing to market include a Raspberry Lemonade and their High Spirits Awards-winning Sparkling Grapefruit.
Hydro-Caffeine could be a huge winner for both consumers and Rexis shareholders; caffeine is a very popular energy stimulant. Not only does caffeine give you energy but it can reduce the risk of cardiovascular disease and type 2 diabetes and improve longevity, which is why caffeine is so popular in the U.S. and abroad. While coffee and tea are the most common ways to get a caffeine fix, energy drinks, caffeine pills and supplements are also popular. In fact, the global energy drinks market is poised to reach $108.4 billion by 2031, growing at a CAGR of 8.2% from 2022 to 2031.
In the U.S. 93% of Americans say they consume caffeine, with 75% partaking in it daily, according to the International Food Information Council. One-quarter of that group consumes caffeine three or more times a day. It is the latter group that worries doctors. Caffeine overdose is real and can lead to several issues including insomnia, jitters, anxiety, elevated heart rate and headaches. It tends to happen a lot since many Americans underestimate the safe amount of caffeine to consume and still remain healthy. Worse, the International Food Information Council found nearly 29% of consumers in the U.S. say they dont know what the safe amount of caffeine is.
The Secret Sauce
Rexis says that with Squared Energy, you need not worry about getting too much or too little caffeine to reap the benefits. The secret behind it is the Hydro-Caffeine fibers which are absorbed more efficiently and rapidly through sublingual and buccal absorption in the cheeks and mouth. That differs from traditional energy drinks, which use a form of encapsulated caffeine in which the caffeine is coated with a sugar-type substance to eliminate bitter flavors. That process increases the time it takes to absorb, decreasing the portion introduced into circulation. The caffeine then must be processed by first-pass metabolism, which reduces efficacy even more. As a result, Rexis says you may receive as much as 25% less of the ingredient in your system than what is said on the packaging.
Shaking Up The Market
Rexiss potentially game-changing Squared Energy drink isnt the only way the biotech is shaking up the consumer markets. With its proprietary nanotechnology, it can improve the potency, taste and speed of effectiveness in everything from energy drinks to cannabis-infused beverages. The goal of Rexis Biotech is to be the Nvidia Corp. (NASDAQ: NVDA) or Intel Corp. (NASDAQ: INTC) of the consumer packaged goods industry. It envisions a world where brands license Rexiss nanotechnology to enhance everything from drinks to food. To meet that end Rexis also manufactures and distributes products for companies including Hemp D9 beverages for 3Chi and functional mushrooms for First Person. It also licenses its technology to brands in the regulated cannabis market including Smokiez and Happy Valley.
Caffeine will always be a preferred way to get a boost, but that doesnt mean consumers have to accept the negative side effects. Jitters, headaches and elevated heart rates could become a thing of the past thanks to Rexis Biotech.
Rexis Biotech is currently raising funds to support its growth. Click here to learn more about Rexis Biotechs crowdfunding raise, and how to invest in the company the founders are modeling after Nvidia!
Featured photo by Mark Daynes on Unsplash.
Rexis is the industry leader and pioneer in developing Hydrophobic Molecule Delivery systems. Leading in the innovation, production and formulation of water based ingredients for use in the Pharmaceutical and Consumer Packaged goods industry. Established in 2022, Rexis is building a core mix of proprietary IP used to sustain strong sales models with pharmaceutical licensees, consumer packaged goods manufacturers and clinical research teams.
This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice.
Contact Details
Ryan Erving
Company Website
View source version on newsdirect.com: https://newsdirect.com/news/no-more-jitters-company-says-its-hydro-caffeinetm-improves-your-morning-caffeine-fixs-benefits-by-400-500-586826653
Rexis Biotech
COMTEX_448717636/2655/2024-03-04T08:27:03
Disclaimer: The views, suggestions, and opinions expressed here are the sole responsibility of the experts. No Euro Tidings journalist was involved in the writing and production of this article.